drugset / Trial / NCT00555542

An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis

NCT00555542 ↗

Phase 2 Completed 10 enrolled Chinese University of Hong Kong
NaSingle-groupOpen-labelTreatment

Summary

To study the effects of T cell in peripheral blood of patients with RA undergoing selective B cell depletion have not been studied. We analyze the B and T cell subsets in patients with active RA treated undergoing this form of treatment with rituximab.

Timeline

Start
2006-07
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rituximab Monoclonal antibody 1000 mg Intravenous

Indications